Physician prescribing patterns of innovative antidepressants in the United States: The case of MDD patients 1993-2007

International Journal of Psychiatry in Medicine

Volumn 42, Issue 4, 2011, Pages 353-368

  Lin, Hsien Chang ^a   Erickson, Steven R ^b   Balkrishnan, Rajesh ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

antidepressant; major depressive disorder (MDD); prescribing; SNRI; sociological factor; SSRI

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEDICAL FEE; MEDICARE; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; PRIVATE HEALTH INSURANCE; RACE; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DECISION THEORY; DEPRESSIVE DISORDER, MAJOR; DRUG UTILIZATION; DRUGS, INVESTIGATIONAL; ETHNIC GROUPS; FEMALE; HUMANS; INSURANCE COVERAGE; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN-PATIENT RELATIONS; SEROTONIN UPTAKE INHIBITORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84863154288     PISSN: 00912174     EISSN: 15413527     Source Type: Journal    
DOI: 10.2190/PM.42.4.b     Document Type: Article

References (32)

1. Compton WM, Conway KP, Stinson FS, et al. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. The American Journal of Psychiatry 2006;163:2141-2147. (Pubitemid 46114235)
2. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005;62:593-602. (Pubitemid 40973434)
3. The World Health Organization. The World Health Report 2004: Changing History. Geneva: WHO, 2004.
4. Simon GE, VonKorff M, Heiligenstein JH, et al. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants. Journal of the American Medical Association 1996;275:1897-1902. (Pubitemid 26196450)
5. Nelson JC. Safety and tolerability of the new antidepressants. The Journal of Clinical Psychiatry 1997;58(Suppl 6):26-31.
6. Mason J, Freemantle N, Eccles M. Fatal toxicity associated with antidepressant use in primary care. The British Journal of General Practice: The Journal of the Royal College of General Practitioners 2000;50:366-370. (Pubitemid 30245614)
7. Williams JW Jr, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Annals of Internal Medicine 2000;132:743-756. (Pubitemid 30244176)
8. Frank L, Revicki DA, Sorensen SV, et al. The economics of selective serotonin reuptake inhibitors in depression: A critical review. CNS Drugs 2001;15:59-83. (Pubitemid 32128491)
9. Langreth R. High anxiety: Rivals threaten Prozac. Wall Street Journal 1996;9:B1-B2.
10. Glaser M. Annual Rx survey. Drug Topics 1997;141:45-53.
11. Katon W, Sullivan MD. Depression and chronic medical illness. The Journal of Clinical Psychiatry 1990;51(Suppl.):3-11; discussion 12-4. (Pubitemid 20212857)
12. Keller MB, Kocsis JH, Thase ME, et al. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial. Journal of the American Medical Association 1998;280:1665-1672. (Pubitemid 28532989)
13. Lewinsohn PM, Zeiss AM, Duncan EM. Probability of relapse after recovery from an episode of depression. Journal of Abnormal Psychology 1989;98:107-116. (Pubitemid 19134398)
14. Depression Guideline Panel. Clinical practice guideline: Depression in primary care. Maryland: U.S. Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research, 1993.
15. Ramana R, Paykel ES, Cooper Z, et al. Remission and relapse in major depression: Atwo-year prospective follow-up study. Psychological Medicine 1995;25:1161-1170.
16. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). The American Journal of Psychiatry 2000;157:1-45.
17. Sleath B, Shih YC. Sociological influences on antidepressant prescribing. Social Science & Medicine 2003;56:1335-1344. (Pubitemid 36216330)
18. Miranda J, Cooper LA. Disparities in care for depression among primary care patients. Journal of General Internal Medicine 2004;19:120.
19. Wells K. Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care. The American Journal of Psychiatry 2001;158:2027.
20. Chen J. Racial and ethnic disparities in antidepressant drug use. The Journal of Mental Health Policy and Economics 2008;11:155.
21. Harman JS. Disparities in the adequacy of depression treatment in the United States. Psychiatric Services 2004;55:1379.
22. Tamblyn R, McLeod P, Hanley JA, et al. Physician and practice characteristics associated with the early utilization of new prescription drugs. Medical Care 2003; 41:895-908.
23. Wilkes MS, Bell RA, Kravitz RL. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Affairs (Project Hope) 2000;19:110-128.
24. Leffler KB. Persuasion or information-The economics of prescription drug advertising. The Journal of Law Economics 1981;24:45.
25. Eisenberg JM. Sociologic influences on decision-making by clinicians. Annals of Internal Medicine 1979;90:957-964.
26. National Hospital Ambulatory Medical Care Survey. Public-use data file and documentation, 2009.
27. Heckman JJ. Sample selection bias as a specification error. Econometrica 1979; 47:153-161.
28. Lee ES, Forthofer RN, Lorimor RJ. Analysis of complex sample survey data: Problems and strategies. Sociological Methods Research 1986;15:69.
29. Madrian BC. Employment-based health insurance and job mobility: Is there evidence of job-lock? The Quarterly Journal of Economics 1994;109:27-54.
30. Dobscha SK, Gerrity MS, Corson K, et al. Measuring adherence to depression treatment guidelines in a VA primary care clinic. General Hospital Psychiatry 2003; 25:230-237. (Pubitemid 36802267)
31. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Archives of General Psychiatry 1998;55:1128-1132. (Pubitemid 28558286)
32. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Annals of Internal Medicine 2007;147:320-329. (Pubitemid 351664559)